Hong Kong Pharma Digital Technology Holdings Limited (HKPD) Key Metrics
HKPD valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $5.4M
- Enterprise value
- $6.8M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 0.4
- Price / book
- 0.6
- EV / EBITDA
- 21.9
- Dividend yield
- —
- Beta
- —
HKPD key metrics, FY2023–FY2026
Fiscal year ended March 31, 2026 · U.S. dollarsHKPD valuation Price multiples at each fiscal year-end price.
HKPD returns How much profit the business earns on the capital it uses.
HKPD per-share figures Results divided by the shares outstanding at year-end.
HKPD financial health Debt, liquidity and how easily interest is covered.
HKPD efficiency & capital use Working capital cycle and where the cash goes.
HKPD valuation history
HKPD returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
HKPD debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
HKPD price vs earnings per share
HKPD key metrics
FY2023–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Valuation | ||||
| Market capitalization | $13.4M | $11.0M | — | — |
| Enterprise value | $14.4M | $10.4M | — | — |
| Price / sales | 1.0 | 0.5 | — | — |
| Price / book | 1.4 | 2.2 | — | — |
| Price / free cash flow | — | 26.6 | — | — |
| Price / operating cash flow | — | 19.4 | — | — |
| EV / sales | 1.1 | 0.5 | — | — |
| EV / EBITDA | — | 8.6 | — | — |
| EV / free cash flow | — | 25.1 | — | — |
| Earnings yield | −8.5% | −0.2% | — | — |
| Free cash flow yield | −5.9% | 3.8% | — | — |
| Share price at fiscal year-end | $0.57 | $1.08 | — | — |
| Per share | ||||
| Revenue per share | $0.57 | $1.99 | — | $1.14 |
| Earnings per share | −$0.05 | −$0.00 | — | $0.09 |
| Operating cash flow per share | −$0.03 | $0.06 | — | $0.16 |
| Free cash flow per share | −$0.03 | $0.04 | — | $0.15 |
| Cash per share | $0.01 | $0.29 | — | $0.05 |
| Book value per share | $0.41 | $0.49 | — | $0.05 |
| Tangible book value per share | $0.40 | $0.48 | — | $0.05 |
| Capex per share | $0.00 | $0.02 | — | $0.01 |
| Debt per share | $0.05 | $0.23 | — | $0.06 |
| Shares outstanding | 23.5M | 10.2M | — | 11.0M |
| Change in shares outstanding | +130.3% | — | — | — |
| Returns & profitability | ||||
| Return on equity (ROE) | −15.6% | −0.6% | 55.0% | 170.6% |
| Return on invested capital (ROIC) | −10.5% | 1.3% | 43.3% | 135.8% |
| Return on assets (ROA) | −10.2% | −0.3% | 22.0% | 29.3% |
| Return on tangible assets | −8.9% | −0.3% | 15.4% | 29.3% |
| Free cash flow margin | −5.9% | 2.0% | −2.9% | 12.8% |
| Income quality (OCF / net income) | — | — | −0.30 | 1.73 |
| Financial health | ||||
| Total debt | $1.3M | $2.4M | $2.1M | $691,076 |
| Cash & short-term investments | $221,841 | $3.0M | $619,575 | $524,613 |
| Net debt | $1.0M | −$630,681 | $1.5M | $166,463 |
| Debt / equity | 0.13 | 0.48 | 0.49 | 1.18 |
| Debt / assets | 0.10 | 0.25 | 0.24 | 0.20 |
| Net debt / EBITDA | — | −0.52 | 0.58 | 0.09 |
| Current ratio | 3.86 | 2.99 | 2.46 | 1.08 |
| Quick ratio | 3.75 | 2.80 | 2.16 | 1.00 |
| Interest coverage | -7.5 | 1.4 | 19.4 | 44.9 |
| Working capital | $9.1M | $5.8M | $4.6M | $198,404 |
| Invested capital | $10.6M | $4.4M | $5.7M | $751,705 |
| Tangible asset value | $9.5M | $4.9M | $4.2M | $581,213 |
| Net current asset value | $9.1M | $4.3M | $3.4M | −$73,048 |
| Graham number | — | — | — | $0.33 |
| Graham net-net per share | −$0.00 | $0.23 | — | −$0.08 |
| Capital allocation | ||||
| Capex / revenue | 0.3% | 0.8% | 0.5% | 0.9% |
| Capex / operating cash flow | — | 27.2% | — | 6.8% |
| Capex / depreciation | 0.05 | 0.14 | 0.10 | 0.16 |
| SG&A / revenue | 17.8% | 10.9% | 11.3% | 14.0% |
| Efficiency | ||||
| Days sales outstanding | 115.6 | 75.8 | 59.2 | 49.4 |
| Days of inventory on hand | 13.9 | 15.2 | 15.6 | 7.1 |
| Days payables outstanding | 49.5 | 31.1 | 37.9 | 52.1 |
| Cash conversion cycle (days) | 80.1 | 59.9 | 37.0 | 4.4 |
| Receivables turnover | 3.16 | 4.82 | 6.16 | 7.40 |
| Payables turnover | 7.37 | 11.73 | 9.64 | 7.01 |
| Inventory turnover | 26.19 | 23.97 | 23.36 | 51.43 |
| Asset turnover | 1.21 | 2.25 | 2.76 | 3.69 |
| Average receivables | $4.3M | $4.2M | $2.7M | $1.7M |
| Average payables | $1.6M | $1.5M | $1.4M | $1.4M |
| Average inventory | $460,044 | $746,640 | $562,093 | $190,887 |
| Intangibles / total assets | 0.6% | 1.0% | 0.4% | 0.1% |
Computed from HKPD's annual financial statements (latest annual report filed August 7, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
HKPD valuation and financial ratios
Hong Kong Pharma Digital Technology earned a return on equity of −15.6% and a return on invested capital of −10.5% in fiscal 2026. It ended the year with $1.3 million of debt and $0.2 million in cash and short-term investments, net debt of $1.0 million.
See the HKPD income statement, the HKPD chart for price history, or the HKPD stock overview for the latest quote and news.
HKPD key metrics FAQ
What is Hong Kong Pharma Digital Technology's return on equity?
Hong Kong Pharma Digital Technology's return on equity (ROE) was −15.6% in fiscal 2026: net income of -$1.1 million on average shareholders' equity of $7.3 million.
What is Hong Kong Pharma Digital Technology's ROIC?
Hong Kong Pharma Digital Technology's return on invested capital was −10.5% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Hong Kong Pharma Digital Technology have?
Hong Kong Pharma Digital Technology had total debt of $1.3 million at the end of fiscal 2026, a debt-to-equity ratio of 0.13.
What is Hong Kong Pharma Digital Technology's free cash flow yield?
Hong Kong Pharma Digital Technology generated -$0.8 million of free cash flow in fiscal 2026, a free cash flow yield of −5.9% on its market value at year-end ($13.4 million).
What is Hong Kong Pharma Digital Technology's current ratio?
Hong Kong Pharma Digital Technology's current ratio was 3.86 at the end of fiscal 2026: current assets were 3.86 times current liabilities.